ENJAYMO sol perf 1100 mg/22ml flac 22 ml
7680680740019
CH-68074
L04AJ04
07.15.0.
1 / 3
google
Details
- Product number
- 6807401
- CPT
- -
- Packaging group
- 1 x 22 ml
- Unit
- Durchstechflasche(n)
- Composition
- sutimlimabum 50 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.45 mg.
Articles (1)
Enjaymo 1100 mg/22 ml, Infusionslösung
Infusionslösung
1 x 22 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.45 MG | Substance | HBESI |
Authorization holder
RECORDATI AG
4057 Basel
Authorization information
- Swissmedic authorization number
- 68074
- Drug name
- Enjaymo, Infusionslösung
- Galenic form
- LSINF
- ATC Code
- L04AJ04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/06/2023
- Authorization expiration date
- 20/06/2028
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENJAYMO sol perf 1100 mg/22ml flac 22 ml
- Description (DE)
- ENJAYMO Inf Lös 1100 mg/22ml Durchstf 22 ml
- Market launch
- 21/06/2023
- Narcotic (BTM)
- No